热门资讯> 正文
Cleveland BioLabs Q1 EPS $(0.800) Down From $(0.110) YoY, Sales $156.000K Down From $227.576K YoY
2020-05-15 21:06
Cleveland BioLabs (NASDAQ:CBLI) reported quarterly losses of $(0.800) per share. This is a 627.27 percent decrease over losses of $(0.110) per share from the same period last year. The company reported $156.000 thousand in sales this quarter. This is a 31.45 percent decrease over sales of $227.576 thousand the same period last year.
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
